Pre-scored Glass Wafer Lowering the Cost of Biochips
Written by Iris Weinreich
Whether you are developing a glass biochip for inhouse use, or as a commercial product, cost-of-good (COGs) has always been at the top of consideration list. Key to managing COGs is the ability to keep costs as low as possible in small quantities whilst still taking advantage of economy of scale as demand increases. This is particularly challenging with customized glass chips.
Microfluidic product development: Guiding principles to de-risk your development program
Written by Micah Atkin
When it comes to managing and mitigating product development risk, there are six guiding principles that are proven to work.
Point of care diagnostic manufacturing. Three key ways to reduce the cost of goods.
Written by Dieter Cronauer
Taking a long-term view at the outset of the cartridge development program is critical for reducing the cost of goods (COGS) when the time inevitably comes to ramp up manufacturing volume.
MISSION CRITICAL: Successful Assay Translation from Benchtop to Microfluidic Environments
Edward Wilkinson, Vice President of SCHOTT MINIFAB USA and Head of Strategy, explains why a fully integrated bioscience and engineering approach is the key to risk mitigation.
